Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Wright

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Scientific Reports|February 26, 2021
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid cultureElise Y Cai, Jose Garcia, Yuzhen Liu, et al.
Clinical Genitourinary Cancer|May 19, 2024
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder CancerElizabeth L Koehne, Dimitra R Bakaloudi, Fady Ghali, et al.
Cancer|May 5, 2016
Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomesIrene M Shui, Chao-Jen Wong, Shanshan Zhao, et al.
Clinical Genitourinary Cancer|June 21, 2023
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy StudyFady Ghali, Funda Vakar-Lopez, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate CancerShanshan Zhao, Milan S Geybels, Amy Leonardson, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
Urologic Oncology|December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapyPetros Grivas, Tarek A Bismar, Aijai S Alva, et al.
Urologic Oncology|April 17, 2018
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomyBrian R Winters, Funda Vakar-Lopez, Lisha Brown, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Scientific Reports|February 26, 2021
A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid cultureElise Y Cai, Jose Garcia, Yuzhen Liu, et al.
Clinical Genitourinary Cancer|May 19, 2024
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder CancerElizabeth L Koehne, Dimitra R Bakaloudi, Fady Ghali, et al.
Cancer|May 5, 2016
Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomesIrene M Shui, Chao-Jen Wong, Shanshan Zhao, et al.
Clinical Genitourinary Cancer|June 21, 2023
Metastatic Bladder Cancer Expression and Subcellular Localization of Nectin-4 and Trop-2 in Variant Histology: A Rapid Autopsy StudyFady Ghali, Funda Vakar-Lopez, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate CancerShanshan Zhao, Milan S Geybels, Amy Leonardson, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.
Urologic Oncology|December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapyPetros Grivas, Tarek A Bismar, Aijai S Alva, et al.
Urologic Oncology|April 17, 2018
Mechanistic target of rapamycin (MTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomyBrian R Winters, Funda Vakar-Lopez, Lisha Brown, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
Pageof 21